Skip to main content
NCBI home page
Oncotarget logoLink to Oncotarget
. 2017 Mar 6;8(10):17406. doi: 10.18632/oncotarget.15921

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C Rowat, Sagar L Patil, Clara K Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A Moore, Jacquie E Schein, Andrew J Mungall, Jinsong Liu, Chad V Pecot, Anil K Sood, Steven JM Jones, Marco A Marra, Preethi H Gunaratne
PMCID: PMC5370050  PMID: 28403581

Present:

ACKNOWLEDGMENTS

The authors gratefully acknowledge the data production teams at the Genome Sciences Centre.

Corrected:

ACKNOWLEDGMENTS

The authors gratefully acknowledge the data production teams at the Genome Sciences Centre. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov.

Original article: Oncotarget. 2016; 7(18):25930–48. doi: 10.18632/oncotarget.8412.

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES